The 3rd Subcommittee on Rare Cancers

Press Releaseopen close

Agenda

1. Pathophysiological Mechanism of Rare Disease Using Patient-Derived iPS Cells and Drug Discovery (Dr. Junya Toguchida, a Member of the Subcommittee)
2. Study of Hematological Immunity Disorders Using iPS Cells (Dr. Toshio Heike, a Member of the Subcommittee)
3. Development of Gene Therapy and Immunotherapy (Dr. Kenzaburo Tani, a Member of the Subcommittee)
4. Points to Consider and Future Plan

List of Handouts

• Document 1 Responsible Party (Draft)
• Document 2 The 2nd Subcommittee Minutes Summary
• Document 3 The 1st-2nd Subcommittee Discussion Summary
• Document 4 Lecture Materials (Dr. Junya Toguchida, a Member)
• Document 5 Lecture Materials (Dr. Toshio Heike, a Member)
• Document 6 Lecture Materials (Dr. Kenzaburo Tani, a Member)